Why fee-for-service can have a place in a reimagined healthcare system, but not as the primary mode of payment
Fee-for-service came under fire during a workshop in which prominent healthcare industry experts spoke of ways to achieve better integration of financing and care delivery.
Study quantifies the cost to physician practices of participating in the Merit-based Incentive Payment System
MIPS participation led to high administrative costs and a significant time drain, according to new research.
Survey data highlights shortcomings in private insurance coverage compared with Medicare
Indicators of coverage gaps were more likely to be seen among individuals with private insurance.
New CMS Administrator Chiquita Brooks-LaSure gets ready to tackle surprise billing, rural healthcare and much more
During her Senate confirmation hearing, Brooks-LaSure said strengthening Medicare, Medicaid and the Affordable Care Act to bolster quality and access while lowering costs will be paramount.
Democratic congressional leaders ramp up efforts to craft a health insurance public option, generating hospital pushback
Leading Democrats in the House and Senate sent out a request for information to healthcare stakeholders, seeking input as they look to establish a public option for health insurance.
CMS is curtailing voluntary participation in the Comprehensive Care for Joint Replacement bundled payment model
Hospitals that participated in the Comprehensive Care for Joint Replacement model on a voluntary basis over the last three years will be excluded after Sept. 30.
In a win for hospitals, CMS removes a rate-reporting requirement from the Medicare FY22 Inpatient Prospective Payment System
An FY22 requirement for hospitals to disclose privately negotiated MA rates on their Medicare cost reports has been rescinded in the proposed rule for the Inpatient Prospective Payment System.
Key payment details in the Medicare FY22 Inpatient Prospective Payment System proposed rule
CMS’s FY22 proposed rule for the Inpatient Prospective Payment System includes a 2.8% payment increase for general acute care hospitals.
Update on Medicare payment policy for treatments involving bamlanivimab
Medicare no longer will pay healthcare providers for administering the COVID-19 treatment bamlanivimab now that the FDA has revoked the Emergency Use Authorization for treatments in which the drug is administered alone.
CMMI announces Direct Contracting participants but cancels second round of applications
The Center for Medicare & Medicaid Innovation announced the 53 entities that have been accepted as participants in the new Global and Professional Direct Contracting model.